

Artificial Organ and Tissues Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Artificial Organ and Tissues market is experiencing robust growth, driven by advancements in biotechnology and increasing demand for organ transplantation. The market size is projected to reach approximately $30 billion by 2027. Factors such as rising chronic diseases and technological innovations are key drivers influencing market dynamics and expansion.
◍ Fresenius Medical Care
◍ Cochlear
◍ Abiomed
◍ ABBOTT
◍ Baxter
◍ B.Braun
◍ Asahi Kasei Corporation
◍ Nipro
◍ MED-EL
◍ Toray Medical
◍ Sonova
◍ Medtronic
◍ Getinge (Maquet)
◍ William Demant
◍ LivaNova (Sorin)
◍ Terumo
◍ Hangzhou Nurotron
The Artificial Organ and Tissues Market features leading companies like Fresenius Medical Care and Cochlear, focusing on advanced medical devices and organ substitutes. These companies innovate through product development and strategic partnerships, driving market growth. Notable revenue figures include:
- Fresenius Medical Care: $19.6 billion
- Abbott: $43 billion
- Medtronic: $30.1 billion Request Sample Report
◍ Syncardia
◍ Artificial Kidney
◍ Cochlear Implant ◍ Artificial Lung ◍ Artificial Liver ◍ Artificial Pancreas ◍ Bionic Hands & Prosthetics ◍ Others ◍ Medical Use ◍ Clinical Research
◍ Artificial Heart & Ventricular Assist Device
Request Sample Report
Request Sample Report
$ X Billion USD